Learn about ergothioneine and its potential use for cognitive impairment, dementia, Alzheimer's disease, Parkinson's disease, cataract, or kidney disease, as well as its safety and cost of supplements containing this ingredient
H., & Brand-Saberi, B
For those engaged in legitimate peptide research, the coming years will bring exciting developments as phase 3 trials conclude and new data emerges
Animal reuse: balancing scientific integrity and animal welfare
In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension